1. Home
  2. LIXT vs HCWC Comparison

LIXT vs HCWC Comparison

Compare LIXT & HCWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • HCWC
  • Stock Information
  • Founded
  • LIXT 2005
  • HCWC N/A
  • Country
  • LIXT United States
  • HCWC
  • Employees
  • LIXT N/A
  • HCWC N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • HCWC
  • Sector
  • LIXT Health Care
  • HCWC
  • Exchange
  • LIXT Nasdaq
  • HCWC NYSE
  • Market Cap
  • LIXT 6.3M
  • HCWC 7.4M
  • IPO Year
  • LIXT N/A
  • HCWC N/A
  • Fundamental
  • Price
  • LIXT $1.27
  • HCWC $0.74
  • Analyst Decision
  • LIXT
  • HCWC
  • Analyst Count
  • LIXT 0
  • HCWC 0
  • Target Price
  • LIXT N/A
  • HCWC N/A
  • AVG Volume (30 Days)
  • LIXT 155.3K
  • HCWC N/A
  • Earning Date
  • LIXT 03-18-2025
  • HCWC N/A
  • Dividend Yield
  • LIXT N/A
  • HCWC N/A
  • EPS Growth
  • LIXT N/A
  • HCWC N/A
  • EPS
  • LIXT N/A
  • HCWC N/A
  • Revenue
  • LIXT N/A
  • HCWC N/A
  • Revenue This Year
  • LIXT N/A
  • HCWC N/A
  • Revenue Next Year
  • LIXT N/A
  • HCWC N/A
  • P/E Ratio
  • LIXT N/A
  • HCWC N/A
  • Revenue Growth
  • LIXT N/A
  • HCWC N/A
  • 52 Week Low
  • LIXT $1.25
  • HCWC N/A
  • 52 Week High
  • LIXT $4.40
  • HCWC N/A
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 28.82
  • HCWC N/A
  • Support Level
  • LIXT $1.35
  • HCWC N/A
  • Resistance Level
  • LIXT $3.00
  • HCWC N/A
  • Average True Range (ATR)
  • LIXT 0.26
  • HCWC 0.00
  • MACD
  • LIXT -0.13
  • HCWC 0.00
  • Stochastic Oscillator
  • LIXT 1.15
  • HCWC 0.00

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About HCWC HEALTHY CHOICE WELLNESS CORP

Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.

Share on Social Networks: